EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MRAS: Master Regulator Analysis of Alternative Splicing

Lei Zhou, Yue Huang, Yang Zhao, Dan Guo, Xiao Wen, Ruihong Xu, Xuan Lv, Song Wu, Sicheng Jing, Zhaoqi Liu iD

Advanced Science · 2025-06 · 12 (21)

DOI: 10.1002/advs.202414493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 05.05.2025. Verfasst von Lei Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: China National Center for Bioinformation, Beijing, 100101, China. Hauptthemen laut MEDLINE: Alternative Splicing, Neoplasms, RNA Splicing Factors, Computational Biology. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a molecular feature that characterizes most tumor types, cancer‐associated splicing dysregulation largely arises from recurrent genetic mutations and altered expression of trans ‐acting splicing factors. Although splicing factor mutations occur less frequently in solid tumors, splicing disorders are pervasive and proven to promote tumorigenesis. However, it still lacks an efficient way to identify the key splicing factors at the top regulatory hierarchy whose abnormal expressions induce such splicing disorders and drive phenotypic variability. Here, MRAS (Master Regulator analysis of Alternative Splicing) is introduced, a computational method designed to pinpoint the pivotal splicing factors that play a central role in shaping splicing regulatory networks and influencing cellular processes. MRAS is demonstrated its power by identifying master splicing regulators associated with various disease phenotypes, including tumor initiation, progression, metastasis, and treatment resistance. Moreover, by applying MRAS to single‐cell RNA‐seq data, crucial regulatory relationships that govern cell‐type specific splicing programs have been uncovered. Overall, MRAS presented as an accurate and versatile approach to unraveling the underlying mechanism of splicing regulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alternative SplicingNeoplasmsRNA Splicing FactorsComputational BiologyHumans

Stichwörter der Autor:innen

RNA binding proteinalternative splicingmaster regulator analysissplicing regulatory network

Substanzen

RNA Splicing Factors

Autor:innen und Institutionen

  • China National Center for Bioinformation, Beijing, 100101, China.
  • Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100101, China.
  • University of Chinese Academy of Sciences, Beijing, 100049, China.
  • National Genomics Data Center, China National Center for Bioinformation, Beijing, 100101, China.
  • Department of Biology, University of California San Diego, San Diego, CA, 92122, USA.

ORCID-Profile: Zhaoqi Liu

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Zhou, L., Huang, Y., Zhao, Y., Guo, D., Wen, X., Xu, R., Lv, X., Wu, S., Jing, S., & Liu, Z. (2025). MRAS: Master Regulator Analysis of Alternative Splicing. Advanced Science, 12(21). https://doi.org/10.1002/advs.202414493

Vancouver

Zhou L, Huang Y, Zhao Y, Guo D, Wen X, Xu R, et al. MRAS: Master Regulator Analysis of Alternative Splicing. Advanced Science. 2025;12(21). doi:10.1002/advs.202414493

BibTeX
@article{Zhou2025,
  author = {Zhou, Lei and Huang, Yue and Zhao, Yang and Guo, Dan and Wen, Xiao and Xu, Ruihong and Lv, Xuan and Wu, Song and Jing, Sicheng and Liu, Zhaoqi},
  title = {MRAS: Master Regulator Analysis of Alternative Splicing},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {21},
  doi = {10.1002/advs.202414493}
}
Kostenlos starten →